Nomogram predictive model of post-operative recurrence in non-functioning pituitary adenoma

被引:17
作者
Lyu, Wen [1 ,2 ]
Fei, Xu [1 ,2 ]
Chen, Cheng [1 ,2 ]
Tang, Yuqun [3 ]
机构
[1] Jinan Univ, Clin Med Coll 2, Shenzhen Peoples Hosp, Dept Neurosurg, Shenzhen 518020, Peoples R China
[2] Southern Univ Sci & Technol, Affiliated Hosp 1, Dept Neurosurg, Shenzhen 518020, Peoples R China
[3] 74th Army Hosp PLA, Dept Oncol, Guangzhou, Peoples R China
关键词
Non-functioning pituitary adenoma (NFPA); recurrence; nomogram; SURGERY; MANAGEMENT; RADIOTHERAPY; PATHOGENESIS; EXPRESSION;
D O I
10.21037/gs-21-47
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: To analyze and predict the possibility of post-operative recurrence in non-functioning pituitary adenoma (NFPA) patients, we investigated the clinical factors leading to tumor recurrence and built a nomogram predictive model based on these risk factors. Methods: A single-center retrospective study was performed. A total of 145 NFPA patients who underwent surgical treatment at Shenzhen People's Hospital from September 2013 to January 2019 were selected. Among them, 52 patients were diagnosed with recurrence of NFPA according to follow-up investigations. Binary logistic regression analysis was used to determine the significant risk factors. A nomogram model was then built to predict recurrence using these factors. Results: The univariate analysis and the binary logistic regression analysis showed that age, tumor size, cavernous invasion, sphenoid sinus invasion, and surgical extension were significant factors affecting tumor recurrence. We then built a nomogram model to predict post-operative recurrence in NFPA patients using these factors. The correlation analysis indicated that sphenoid sinus invasion [hazard ratio (HR) = 13.14, 95% confidence interval (CI): 7.03-24.58, P<0.0001], cavernous sinus invasion (HR = 7.53, 95% CI: 4.27-13.28, P<0.0001), and tumor size (HR = 11.06, 95% CI: 6.11-20.03, P<0.0001) could promote the recurrence of NFPA. In contrast, advanced age (HR = 0.50, 95% CI: 0.28-0.86, P<0.0001) and gross total resection (HR = 0.12, 95% CI: 0.07-0.22, P<0.0001) could effectively inhibit recurrence. Conclusions: In this study, we developed a nomogram predictive model based on the significant recurrence-associated factors for NFPA. This nomogram may aid neurosurgeons in the post-operative prediction of recurrence, and may facilitate tailored counseling of individual patients.
引用
收藏
页码:807 / 815
页数:9
相关论文
共 35 条
  • [1] Gross total resection of pituitary adenomas after endoscopic vs. microscopic transsphenoidal surgery: a meta-analysis
    Almutairi, Reem D.
    Muskens, Ivo S.
    Cote, David J.
    Dijkman, Mark D.
    Kavouridis, Vasileios K.
    Crocker, Erin
    Ghazawi, Kholoud
    Broekman, Marike L. D.
    Smith, Timothy R.
    Mekary, Rania A.
    Zaidi, Hasan A.
    [J]. ACTA NEUROCHIRURGICA, 2018, 160 (05) : 1005 - 1021
  • [2] The Pathogenesis of Pituitary Tumors
    Asa, Sylvia L.
    Ezzat, Shereen
    [J]. ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2009, 4 : 97 - 126
  • [3] Cabergoline in the Management of Residual Nonfunctioning Pituitary Adenoma A Single-Center, Open-Label, 2-Year Randomized Clinical Trial
    Batista, Rafael L.
    Musolino, Nina R. C.
    Cescato, Valter A. S.
    da Silva, Gilberto O.
    Medeiros, Raphael S. S.
    Herkenhoff, Clarissa G. B.
    Trarbach, Ericka B.
    Cunha-Neto, Malebranche B.
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2019, 42 (02): : 221 - 227
  • [4] Nonfunctioning Pituitary Adenoma Recurrence and Its Relationship with Sex, Size, and Hormonal Immunohistochemical Profile
    Batista, Rafael Loch
    Trarbach, Ericka Barbosa
    Marques, Mateus Diniz
    Cescato, Valter Angelo
    da Silva, Gilberto Ochman
    Borba Herkenhoff, Clarissa G.
    Cunha-Neto, Malebranche Berardo
    Musolino, Nina Rosa
    [J]. WORLD NEUROSURGERY, 2018, 120 : E241 - E246
  • [5] Predicting early post-operative remission in pituitary adenomas: evaluation of the modified knosp classification
    Buchy, Marie
    Lapras, Veronique
    Rabilloud, Muriel
    Vasiljevic, Alexandre
    Borson-Chazot, Francoise
    Jouanneau, Emmanuel
    Raverot, Gerald
    [J]. PITUITARY, 2019, 22 (05) : 467 - 475
  • [6] Long-term recurrence and mortality after surgery and adjuvant radiotherapy for nonfunctional pituitary adenomas
    Chang, Edward F.
    Zada, Gabriel
    Kim, Sang
    Lamborn, Kathleen R.
    Quinones-Hinojosa, Alfredo
    Tyrrell, J. Blake
    Wilson, Charles B.
    Kunwar, Sandeep
    [J]. JOURNAL OF NEUROSURGERY, 2008, 108 (04) : 736 - 745
  • [7] Management of clinically non-functioning pituitary adenoma
    Chanson, Philippe
    Raverot, Gerald
    Castinetti, Frederic
    Cortet-Rudelli, Christine
    Galland, Francoise
    Salenave, Sylvie
    [J]. ANNALES D ENDOCRINOLOGIE, 2015, 76 (03) : 239 - 247
  • [8] Predicting the regrowth of clinically non-functioning pituitary adenoma with a statistical model
    Cheng, Sen
    Wu, Jiaqi
    Li, Chuzhong
    Li, Yangfang
    Liu, Chunhui
    Li, Guilin
    Li, Wuju
    Hu, Shuofeng
    Ying, Xiaomin
    Zhang, Yazhuo
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17 (1)
  • [9] Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review
    Chiloiro, Sabrina
    Bianchi, Antonio
    Doglietto, Francesco
    de Waure, Chiara
    Giampietro, Antonella
    Fusco, Alessandra
    Iacovazzo, Donato
    Tartaglione, Linda
    Di Nardo, Francesco
    Signorelli, Francesco
    Lauriola, Libero
    Anile, Carmelo
    Rindi, Guido
    Maira, Giulio
    Pontecorvi, Alfredo
    De Marinis, Laura
    [J]. PITUITARY, 2014, 17 (03) : 267 - 276
  • [10] Molecular pathogenesis of pituitary tumors
    Farrell, WE
    Clayton, RN
    [J]. FRONTIERS IN NEUROENDOCRINOLOGY, 2000, 21 (03) : 174 - 198